These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8240731)

  • 1. Tumor-rejection antigens recognized by T lymphocytes.
    Finn OJ
    Curr Opin Immunol; 1993 Oct; 5(5):701-8. PubMed ID: 8240731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human tumour antigens recognized by T cells: new perspectives for anti-cancer vaccines?
    Coulie PG
    Mol Med Today; 1997 Jun; 3(6):261-8. PubMed ID: 9211417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor antigens recognized by T lymphocytes.
    Boon T; Cerottini JC; Van den Eynde B; van der Bruggen P; Van Pel A
    Annu Rev Immunol; 1994; 12():337-65. PubMed ID: 8011285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD25+ regulatory T cells and tumor immunity.
    Jones E; Dahm-Vicker M; Golgher D; Gallimore A
    Immunol Lett; 2003 Jan; 85(2):141-3. PubMed ID: 12527220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human tumor antigens recognized by T lymphocytes.
    Boon T; van der Bruggen P
    J Exp Med; 1996 Mar; 183(3):725-9. PubMed ID: 8642276
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor-specific T-cell immunity: ready for prime time?
    Greenberg PD; Riddell SR
    J Natl Cancer Inst; 1992 Jul; 84(14):1059-61. PubMed ID: 1619675
    [No Abstract]   [Full Text] [Related]  

  • 7. Using Autoimmunity To Inform Tumor Immunity.
    Sherman LA
    J Immunol; 2015 Dec; 195(11):5091-5. PubMed ID: 26589742
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor immunology: an overview.
    Hellström I; Hellström KE
    Ann N Y Acad Sci; 1993 Aug; 690():24-33. PubMed ID: 8368741
    [No Abstract]   [Full Text] [Related]  

  • 9. [Identification of human tumor antigens recognized by T cells].
    Kawakami Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():562-7. PubMed ID: 15861711
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor antigens discovery: perspectives for cancer therapy.
    Wang RF
    Mol Med; 1997 Nov; 3(11):716-31. PubMed ID: 9407548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
    Seremet T; Brasseur F; Coulie PG
    Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of immunity in cancer.
    Baldwin RW
    Pathobiol Annu; 1981; 11():155-75. PubMed ID: 6460216
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
    Jäger D; Jäger E; Bert F; Knuth A
    Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor immunology.
    Shu S; Plautz GE; Krauss JC; Chang AE
    JAMA; 1997 Dec; 278(22):1972-81. PubMed ID: 9396660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigens recognized by T-lymphocytes on human tumours.
    Coulie PG; Van den Eynde BJ; van der Bruggen P; Van Pel A; Boon T
    Biochem Soc Trans; 1997 May; 25(2):544-8. PubMed ID: 9191153
    [No Abstract]   [Full Text] [Related]  

  • 16. Human cancer regression antigens.
    Kvistborg P; van Buuren MM; Schumacher TN
    Curr Opin Immunol; 2013 Apr; 25(2):284-90. PubMed ID: 23566921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defined antigens recognized by T lymphocytes on human tumors.
    Coulie PG; Van Pel A
    Curr Opin Oncol; 1993 Nov; 5(6):1043-8. PubMed ID: 8305537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor rejection antigens and tumor specific cytotoxic T lymphocytes.
    Toes RE; Offringa R; Feltkamp MC; Visseren MJ; Schoenberger SP; Melief CJ; Kast WM
    Behring Inst Mitt; 1994 Jul; (94):72-86. PubMed ID: 7998917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escape mechanisms in tumor immunity: an update.
    Müller L; Kiessling R; Rees RC; Pawelec G
    J Environ Pathol Toxicol Oncol; 2002; 21(4):277-330. PubMed ID: 12510961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity.
    Carmi Y; Spitzer MH; Linde IL; Burt BM; Prestwood TR; Perlman N; Davidson MG; Kenkel JA; Segal E; Pusapati GV; Bhattacharya N; Engleman EG
    Nature; 2015 May; 521(7550):99-104. PubMed ID: 25924063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.